Skip to main contentSkip to main content
Updating results

Patient

  • Updated

FRIDAY, Jan. 7, 2022 (HealthDay News) -- It is the ultimate irony: More COVID-19 treatments exist now than at any other time during the pandemic, but the skyrocketing number of cases from the surging omicron variant might mean they cannot be accessed when needed most.

  • Updated

BIRMINGHAM, Ala. (AP) — With most of Alabama’s population still not fully vaccinated against COVID-19, major hospitals are dealing with an influx of patients and asking people to limit emergency room visits as the highly contagious omicron variant takes hold.

  • Updated

LE PECQ, France (AP) — France is allowing health care workers who are infected with the coronavirus but have few or no symptoms to keep treating patients rather than self-isolate, an extraordinary stopgap measure aimed at easing staff shortages at hospitals and other facilities caused by an unprecedented explosion in cases.

  • Updated

Newly infected COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: This Q&A gives you the lowdown the on pills. Plus, other common questions answered.

  • Updated

Merck’s molnupiravir is not authorized for children because it might interfere with bone growth. It also isn't recommended for pregnant women …

Gov. Pete Ricketts said he had heard anecdotal stories that some doctors are reluctant to prescribe the treatment to people who could benefit from it. "It is incredibly frustrating to me that doctors would do that." 

  • Updated

THURSDAY, Dec. 23, 2021 (HealthDay News) -- Many Americans now have two oral antiviral pills that can be taken at home to treat a fresh case of COVID-19. The U.S. Food and Drug Administration on Thursday approved the emergency use of the molnupiravir pill from Merck for the treatment of mild-to-moderate COVID-19 in people who have just tested positive.

Get up-to-the-minute news sent straight to your device.

Topics

Trending

Breaking News